FRAN

In 2004 – preclinical trials.
In 2006 - 2007 – clinical trials of the first and second phase.
In 2015 – development of a suppository, a new formula of the drug named FRAN.

The main advantages of the drug «FRAN» are:

• The ability to cure cancer completely in the initial and middle stages of the disease;
• The drug acts on a wide range of cancers, unlike other drugs (which affect only one type of disease)
• The ability to conduct effective therapy at the most severe stages of diseases even in critical condition of the patient;
• The absolute safety of the drug, it does not cause any side effects actions;
• High antimetastatic action: the use of the drug prevents the development of metastases and reduces the size of existing metastases;
• High preventive effect. Preliminary drug administration prevents the development of cancer.
• Availability of raw materials in any volumes in the domestic market: the raw material base does not depend on imports;

What is the difference between FRAN and existing drugs?
The common properties of all chemotherapeutic drugs are high toxicity and a complete lack of selectivity of action, when the drug acts equally on healthy cells of the body and on cancer cells.

The advantage of our project is the uniqueness of the drug. Unlike all other antitumor drugs, FRAN is an absolutely safe drug of natural origin and it does not contain chemical modifiers. This fact determines the unique therapeutic properties of the drug, which will create a very high demand for it in the future.

Research, as well as the opinion of practicing oncologists, suggests that the combination of positive properties makes it unique, without worthy competitors in the antitumor market. This is proved by preclinical trials, clinical trials and more than 500 people who have already been treated with FRAN.

By the sum of the positive qualities combining high antitumor efficacy, absolute selectivity towards tumor cells and complete absence of toxicity, the drug FRAN is unique in comparison with the well-known chemotherapeutic drugs.

The development of the drug FRAN is a revolutionary solution and it opens up a new direction in the science of creating drugs for the safe treatment of cancer and, which is important, it carries out prophylaxis to restore immunity in order to destroy cancer cells at an early stage.

Already, the drug can be ordered by contacting our representatives on our website ufgroup.pro

Yllo blockchain One

Yllo Messenger is a mobile application for instant messaging, crypto assets and business. Decentralized messenger built on cluster architecture. It does not have a central server. In addition to ordinary communication, it has a built-in crypto wallet for storing and transferring various cryptocurrencies

Crypto platform. On the Yllo platform you can issue any digital asset: with a unique name, logo and rules. The issuer himself sets the parameters of the total emission, inflation, burning, commission, distribution, initial price and any other properties of the asset.

Branding. Any element of the platform (instant messenger, notes, wallet for PC) can be branded as a client, as a personal tool based on Yllo.

Cryptocurrency exchange XLT.One - is a platform for the exchange of classic cryptocurrencies and all crypto assets created in Yllo.

Install the Yllo app for Apple

Website